Diagnostic Value of FDG-PET/CT for Lymph Node Metastasis of Colorectal Cancer

详细信息    查看全文

• 作者：Jae Young Kwak (1)
  Jae Seung Kim (2)
  Hye Jin Kim (3)
  Hyun Kwon Ha (3)
  Chang Sik Yu (1)
  Jin Cheon Kim (14) jckim@amc.seoul.kr
• 刊名：World Journal of Surgery
• 出版年：2012
• 出版时间：August 2012
• 年：2012
• 卷：36
• 期：8
• 页码：1898-1905
• 全文大小：741.4 KB
• 参考文献：1. Cohen AM, Tremiterra S, Candela F et al (1991) Prognosis of node-positive colon cancer. Cancer 67:1859–1861
  2. O’Dwyer ST, Haboubi NY, Johnson JS et al (2001) Detection of lymph node metastases in colorectal carcinoma. Colorectal Dis 3:288–294
  3. Bipat S, Glas AS, Slors FJ et al (2004) Rectal cancer: local staging and assessment of lymph node involvement with endoluminal US, CT, and MR imaging—a meta-analysis. Radiology 232:773–783
  4. Heriot AG, Grundy A, Kumar D (1999) Preoperative staging of rectal carcinoma. Br J Surg 86:17–28
  5. Shin SS, Jeong YY, Min JJ et al (2008) Preoperative staging of colorectal cancer: CT versus integrated FDG PET/CT. Abdom Imaging 33:270–277
  6. Park IJ, Kim HC, Yu CS et al (2006) Efficacy of PET/CT in the accurate evaluation of primary colorectal carcinoma. Eur J Surg Oncol 32:941–947
  7. Erturk SM, Ichikawa T, Fujii H et al (2006) PET imaging for evaluation of metastatic colorectal cancer of the liver. Eur J Radiol 58:229–235
  8. Abdel-Nabi H, Doerr RJ, Lamonica DM et al (1998) Staging of primary colorectal carcinomas with fluorine-18 fluorodeoxyglucose whole-body PET: correlation with histopathologic and CT findings. Radiology 206:755–760
  9. Kantorova I, Lipska L, Belohlavek O et al (2003) Routine [18]F-FDG PET preoperative staging of colorectal cancer: comparison with conventional staging and its impact on treatment decision making. J Nucl Med 44:1784–1788
  10. Bar-Shalom R, Yefremov N, Guralnik L et al (2003) Clinical performance of PET/CT in evaluation of cancer: additional value for diagnostic imaging and patient management. J Nucl Med 44:1200–1209
  11. Ell PJ (2006) The contribution of PET/CT to improved patient management. Br J Radiol 79:32–36
  12. Cohade C, Osman M, Leal J et al (2003) Direct comparison of [18]F-FDG PET and PET/CT in patients with colorectal carcinoma. J Nucl Med 44:1797–1803
  13. Selzner M, Hany TF, Wildbrett P et al (2004) Does the novel PET/CT imaging modality impact on the treatment of patients with metastatic colorectal cancer of the liver? Ann Surg 240:1027–1034 discussion 1035–1026
  14. Japanese Society for Cancer of the Colon and Rectum (2006) Japanese classification of colorectal carcinoma. Kanehara, Tokyo
  15. Antoch G, Saoudi N, Kuehl H et al (2004) Accuracy of whole-body dual-modality fluorine-18-2-fluoro-2-deoxy-d-glucose positron emission tomography and computed tomography (FDG-PET/CT) for tumor staging in solid tumors: comparison with CT and PET. J Clin Oncol 22:4357–4368
  16. Niekel MC, Bipat S, Stoker J (2010) Diagnostic imaging of colorectal liver metastases with CT, MR imaging, FDG PET, and/or FDG PET/CT: a meta-analysis of prospective studies including patients who have not previously undergone treatment. Radiology 257:674–684
  17. Avril N (2004) GLUT1 expression in tissue and [18]F-FDG uptake. J Nucl Med 45:930–932
  18. Inoue K, Sato T, Kitamura H et al (2008) Improvement of the diagnostic accuracy of lymph node metastases of colorectal cancer in 18F-FDG-PET/CT by optimizing the iteration number for the image reconstruction. Ann Nucl Med 22:465–473
  19. Dukes CE, Bussey HJ (1958) The spread of rectal cancer and its effect on prognosis. Br J Cancer 12:309–320
  20. Hermanek P, Altendorf A (1981) Classification of colorectal carcinomas with regional lymphatic metastases. Pathol Res Pract 173:1–11
  21. Kim JS, Sohn DK, Park JW et al (2011) Prognostic significance of distribution of lymph node metastasis in advanced mid or low rectal cancer. J Surg Oncol 104:486–492
  22. Sugihara K, Kobayashi H, Kato T et al (2006) Indication and benefit of pelvic sidewall dissection for rectal cancer. Dis Colon Rectum 49:1663–1672
  23. Di Matteo G, Mascagni D, Tarroni D (1991) Radical surgery for rectal cancer. J Surg Oncol Suppl 2:32–35
  24. Leggeri A, Roseano M, Balani A et al (1994) Lumboaortic and iliac lymphadenectomy: what is the role today? Dis Colon Rectum 37:S54–S61
  25. Hojo K, Sawada T, Moriya Y (1989) An analysis of survival and voiding, sexual function after wide iliopelvic lymphadenectomy in patients with carcinoma of the rectum, compared with conventional lymphadenectomy. Dis Colon Rectum 32:128–133
  26. Blodgett TM, Meltzer CC, Townsend DW (2007) PET/CT: form and function. Radiology 242:360–385
  27. Fong Y, Saldinger PF, Akhurst T et al (1999) Utility of 18F-FDG positron emission tomography scanning on selection of patients for resection of hepatic colorectal metastases. Am J Surg 178:282–287
  28. Desai DC, Zervos EE, Arnold MW et al (2003) Positron emission tomography affects surgical management in recurrent colorectal cancer patients. Ann Surg Oncol 10:59–64
  29. Truant S, Huglo D, Hebbar M et al (2005) Prospective evaluation of the impact of [18F]fluoro-2-deoxy-d-glucose positron emission tomography of resectable colorectal liver metastases. Br J Surg 92:362–369
  30. Lardinois D, Weder W, Hany TF et al (2003) Staging of non-small-cell lung cancer with integrated positron-emission tomography and computed tomography. N Engl J Med 348:2500–2507
  31. Flamen P, Stroobants S, Van Cutsem E et al (1999) Additional value of whole-body positron emission tomography with fluorine-18-2-fluoro-2-deoxy-d-glucose in recurrent colorectal cancer. J Clin Oncol 17:894–901
  32. Chowdhury FU, Shah N, Scarsbrook AF et al (2010) [18F]FDG PET/CT imaging of colorectal cancer: a pictorial review. Postgrad Med J 86:174–182
  33. Wong JH, Severino R, Honnebier MB et al (1999) Number of nodes examined and staging accuracy in colorectal carcinoma. J Clin Oncol 17:2896–2900
  34. Goldstein NS (2002) Lymph node recoveries from 2427 pT3 colorectal resection specimens spanning 45 years: recommendations for a minimum number of recovered lymph nodes based on predictive probabilities. Am J Surg Pathol 26:179–189
  35. Le Voyer TE, Sigurdson ER, Hanlon AL et al (2003) Colon cancer survival is associated with increasing number of lymph nodes analyzed: a secondary survey of intergroup trial INT-0089. J Clin Oncol 21:2912–2919
  36. Pusztaszeri M, Matter M, Kuonen A et al (2009) Nodal staging in colorectal cancer: should distant lymph nodes be recovered in surgical specimens? Hum Pathol 40:552–557
  37. Smith NJ, Bees N, Barbachano Y et al (2007) Preoperative computed tomography staging of nonmetastatic colon cancer predicts outcome: implications for clinical trials. Br J Cancer 96:1030–1036
  38. McDaniel KP, Charnsangavej C, DuBrow RA et al (1993) Pathways of nodal metastasis in carcinomas of the cecum, ascending colon, and transverse colon: CT demonstration. AJR Am J Roentgenol 161:61–64
  39. Granfield CA, Charnsangavej C, Dubrow RA et al (1992) Regional lymph node metastases in carcinoma of the left side of the colon and rectum: CT demonstration. AJR Am J Roentgenol 159:757–761
  40. Pomerri F, Maretto I, Pucciarelli S et al (2009) Prediction of rectal lymph node metastasis by pelvic computed tomography measurement. Eur J Surg Oncol 35:168–173
  41. Dighe S, Swift I, Brown G (2008) CT staging of colon cancer. Clin Radiol 63:1372–1379
  42. Adams MC, Turkington TG, Wilson JM et al (2010) A systematic review of the factors affecting accuracy of SUV measurements. AJR Am J Roentgenol 195:310–320
• 作者单位：1. Department of Colon and Rectal Surgery, University of Ulsan College of Medicine, and Asan Medical Center, Seoul, Korea2. Department of Nuclear Medicine, University of Ulsan College of Medicine, and Asan Medical Center, Seoul, Korea3. Department of Radiology, University of Ulsan College of Medicine, and Asan Medical Center, Seoul, Korea4. Department of Surgery, University of Ulsan College of Medicine, 86 Asanbyeongwon-gil, Songpa-gu, Seoul, 138-736 Korea
• ISSN：1432-2323

文摘

Background Lymph node metastasis is an important prognostic factor in patients with colorectal cancer. We assessed the ability of 18F-fluorodeoxyglucose positron emission tomography/computed tomography (FDG-PET/CT) to diagnose lymph node metastases in colorectal cancer patients.